Hospira Misled Investors To Pump Up Stock Prices: Suit
A pension plan lodged a putative class action Thursday in Illinois federal court accusing cancer drug maker Hospira Inc. and three executives of artificially inflating stock prices in part by withholding...To view the full article, register now.
Already a subscriber? Click here to view full article